Dr. Lawrence Brown Meets with Scientists & Doctors in Phoenix, AZ

Brooklyn, NY - Driven to advance the highest standards in patient diagnosis and neuroscientific understanding,  Dr. Lawrence S. Brown, who is also the CEO of START Treatment & Recovery Centers based in New York City, participated in the 53rd annual meeting of the American College of the Neuropsychopharmacology (ACNP), which occurred in Phoenix, AZ the week of December 7,  2014. Founded in 1961, the ACNP is the nation’s premier organization in conducting brain/behavior and psychopharmacology research.

Leading a health organization that serves patients experiencing a range of medical, mental health and chronic behavioral conditions, Dr. Lawrence Brown invested time at this conference of distinguished scientists and physicians to explore emerging new theoretical concepts that may improve clinical approaches, and ultimately, outcomes for patients. “The exchange of information on current scientific research findings as well as ideas about potential new treatment concepts with colleagues at the American College of Neuropsychopharmacology proved valuable in light of the national push for more integrative care planning.” stated Dr. Lawrence Brown.  

He added, “For our clinical and management team at START Treatment and Recovery Centers, we believe that it’s our duty to participate now in such advanced research circles as a means to help inform our future approach in guiding life changing patient treatment tomorrow.”

According to a report presented during the conference on December 9, 2014 by the American College of Neuropsychopharmacology , a sample group of healthy, elderly research participants who reported being more sleepy and less rested have higher levels of amyloid deposition in regions of the brain that are affected in Alzheimer’s disease. If sleep disturbance is a cause of amyloid accumulation, it may be an early target for intervention to prevent the progression of cognitive deficits in late life. The ACNP is a leading source for exploring such clinical questions.

Over the years, START Treatment & Recovery Centers committed itself identifying evidence-based services. For example, START designed a new cutting-edge Hepatitis C testing and telemedicine patient program. With support from future new partnering organizations, this program could prove very beneficial to patients. For more information, on this promising initiative, please visit our website at startny.org or feel free to call us at (718) 260-2900.